Status:
UNKNOWN
Imagery Rescripting and Imaginal Exposure for Anxiety Symptoms
Lead Sponsor:
Hebrew University of Jerusalem
Conditions:
Social Anxiety
Generalized Anxiety
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study will recruit 460 participants who self-report high symptoms of anxiety. Participants will be randomly assigned to one of 4 groups: one analog intervention of Imagery Rescripting (IR) for me...
Detailed Description
After being informed about the study potential risks, all patients giving written informed consent will undergo screening to determine eligibility for study entry. They will be randomly assigned to on...
Eligibility Criteria
Inclusion
- We will recruit participants based on attainment of SPIN score \>= 24 and/or ASI-3 scores \>=23 and/or OCI-R subscale scores (not including hoarding subscale) \>=6 and/or GAD-7 scores \>= 9 .
Exclusion
- Diagnosis of psychosis, active suicidality, post-traumatic stress disorder, acute stress disorder. Can't report a negative imagery related to a future social scenario. Attending active psychotherapy sessions. Started/stopped taking psychotherapeutic medications in the last 3 months.
Key Trial Info
Start Date :
April 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT05292807
Start Date
April 14 2022
End Date
January 1 2025
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hebrew University of Jerusalem
Jerusalem, Israel, 9190501